Perioperative use of antithrombotic agents: Recommendations of the American College of Chest Physicians (ACCP) and the French Superior Health Authority (HAS);La prise en charge périopératoire des traitements antithrombotiques. Des recommandations de l'American College of Chest Physicians (ACCP) à celles de la Haute Autorité de santé (HAS)

Journal des Maladies Vasculaires

Volumn 35, Issue 4, 2010, Pages 220-234

  Samama, M M ^a   Horellou, M H ^a   Achkar, A ^a   Conard, J ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTICOAGULANT AGENT; ANTIVITAMIN K; CILOSTAZOL; CLOPIDOGREL; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP;

ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BLEEDING; CATARACT EXTRACTION; DENTAL SURGERY; DRUG ELUTING STENT; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; SKIN SURGERY; SURGICAL RISK; THROMBOEMBOLISM; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; FIBRINOLYTIC AGENTS; FRANCE; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SOCIETIES, MEDICAL; TICLOPIDINE; UNITED STATES;

EID: 77955367097     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmv.2010.05.005     Document Type: Article

References (12)

1. th edition). Chest 2008, 133:299S-339S.
2. Douketis J.D., Johnson J.A., Turpie A.G. Low-molecular weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004, 164:1319-1326.
3. Kovacs M.J., Kearon C., Rodger M., Anderson D.R., Turpie A.G., Bates S.M., et al. Single-arm study of bridging therapy with low-mocular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004, 110:1658-1663.
4. Jaffer A.K., Ahmed M., Brotman D.J., Bragg L., Seshadri N., Qadeer M.A., et al. Low-molecular-weight-heparins as periprocedural patients with prosthetic on long term warfarin therapy: a standardized bridgingtherapy protocol. J Thromb Thrombolysis 2005, 20:11-16.
5. Hammerstingl C., Tripp C., Schmidt H., von der Recke G., Omram H. Periprocedural bridging therapy with low-mocular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry. J Heart Valve Dis 2007, 16:285-292.
6. Spyropoulos A.C., Douketis J.D. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation. Int Angiol 2008, 27:333-343.
7. Spyropoulos A.C. To bridge or not to bridge: that is the question. The argument for bridging therapy in patients on oral anticoagulants requiring temporary interruption for elective procedures. J Thromb Thrombolysis 2010, 29:192-198.
8. Ansell J, Hirsch J, Hylek E, Jacobson A, Crother M, Palaretti G. The pharmacology and management of the vitamin K antagonists. The Eighth ACCP Conference on antithrombotic and thrombolytic therapy. American College of Chest Physicians. Chest 2008;133:160S-98S.
9. Fang M.C., Chang Y., Hylek E.M., Rosand J., Greenberg S.M., Go As, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004, 141:745-752.
10. Hylek E.M., Go A.S., Chang Y., Jensvold N.G., Henault L.E., Selby J.V., et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003, 349:1019-1026.
11. Sié P., Bouget J., Boulain T., Castot A., Dumarcet N., Druais P.L., et al. Prise en charge des surdosages en antivitamines K, des situations à risque hémorragique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier. Sang Thrombose Vaisseaux 2008, 20:371-384.
12. Pengo V., Cucchini U., Denas G., Erba N., Guazzaloca G., La Rosa L., et al. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation 2009, 119:2920-2927.